Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 21.50
+0.02 (0.09%)
May 12, 2026, 3:00 PM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.42 billion as of May 12, 2026. Its market cap has increased by 33.17% in one year.
Market Cap
2.42B
Enterprise Value
3.03B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
21.50
Market Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.42B, a decrease of -52.48%. That is a compound annual growth rate of -12.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 2.42B | 20.67% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.17B |
| Landfar Bio-medicine | 3.12B |
| Shandong Sito Bio-technology | 2.95B |
| Jilin Jian Yisheng Pharmaceutical | 2.77B |
| Shanghai Universal Biotech | 2.76B |
| Suzhou Fushilai Pharmaceutical | 2.74B |
| Cabio Biotech (Wuhan) | 2.67B |
| Jiangsu CoWin Biotech | 2.40B |